Sanofi-Aventis Picks Two To Head U.S.: Rothwell, Soriot On Management Committee

Sanofi's Tim Rothwell will continue to serve as U.S. CEO, while Aventis' Soriot will head U.S. commercial operations. French market regulator extends closing date of merger to July 30, citing extra time needed for FTC review.